ABBOTT LABORATORIES - Common Stock (ABT)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ABT on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
1,740,239,592
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,353,052,363
Holdings value
$181,142,797,749
% of all portfolios
0.14%
Number of holders
3,124
Number of buys
1,311
Number of sells
-1,441
Average buys %
+0.01%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ABBOTT LABORATORIES - Common Stock (ABT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10.05% $22,211,548,033 174,894,079 The Vanguard Group 28 Nov 2025

Institutional Holders of ABBOTT LABORATORIES - Common Stock (ABT)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1,353,052,363 $181,142,797,749 -$2,756,892,335 $133.94 3,124
2025 Q2 1,373,456,208 $186,724,449,142 +$3,689,373,499 $136.01 3,150
2025 Q1 1,348,790,206 $178,801,336,976 +$458,110,755 $132.65 3,135
2024 Q4 1,346,298,072 $152,329,939,683 +$4,602,128,635 $113.11 3,033
2024 Q3 1,300,355,763 $148,247,878,720 -$1,716,781,783 $114.01 2,874
2024 Q2 1,316,417,932 $136,784,452,486 +$2,136,359,246 $103.91 2,843
2024 Q1 1,302,852,431 $147,952,633,332 -$186,373,857 $113.66 2,884
2023 Q4 1,304,983,629 $143,636,729,289 +$702,840,266 $110.07 2,868
2023 Q3 1,296,567,862 $125,616,929,945 -$511,707,264 $96.85 2,664
2023 Q2 1,300,801,326 $141,636,058,128 -$238,716,500 $109.02 2,714
2023 Q1 1,303,370,319 $131,997,378,367 +$456,259,624 $101.26 2,685
2022 Q4 1,295,641,185 $142,311,403,748 -$88,117,082 $109.79 2,741
2022 Q3 1,295,186,205 $125,419,250,679 +$340,947,519 $96.76 2,596
2022 Q2 1,292,982,597 $140,507,109,818 +$1,291,772,556 $108.65 2,676
2022 Q1 1,290,037,320 $152,773,075,671 -$1,347,741,981 $118.36 2,744
2021 Q4 1,298,568,047 $182,637,730,877 -$1,037,752,022 $140.74 2,792
2021 Q3 1,304,329,872 $154,105,545,758 -$489,063,797 $118.13 2,518
2021 Q2 1,308,302,318 $151,667,725,087 -$1,382,462,665 $115.93 2,492
2021 Q1 1,318,091,663 $157,927,510,389 +$1,631,328,365 $119.84 2,510
2020 Q4 1,307,462,033 $143,116,956,354 +$331,022,292 $109.49 2,473
2020 Q3 1,306,014,624 $142,022,460,179 -$6,984,888 $108.83 2,293
2020 Q2 1,304,304,663 $119,298,426,006 -$1,426,498,089 $91.43 2,237
2020 Q1 1,320,881,349 $104,282,756,007 -$474,548,989 $78.91 2,118
2019 Q4 1,324,729,656 $115,053,827,077 +$582,610,959 $86.86 2,181
2019 Q3 1,320,917,464 $110,486,349,698 -$172,855,428 $83.67 2,020
2019 Q2 1,320,235,491 $111,014,490,159 +$1,880,435,078 $84.1 2,003
2019 Q1 1,313,334,925 $104,961,645,831 -$610,840,495 $79.94 1,992
2018 Q4 1,321,863,765 $95,580,892,549 +$1,894,141,670 $72.33 1,962
2018 Q3 1,293,120,470 $94,835,420,854 +$2,995,171,785 $73.36 1,856
2018 Q2 1,254,589,153 $76,508,542,840 -$964,494,217 $60.99 1,801
2018 Q1 1,274,488,709 $76,351,995,921 +$368,748,979 $59.92 1,796
2017 Q4 1,267,615,293 $72,341,691,509 -$422,486,325 $57.07 1,746
2017 Q3 1,273,140,330 $67,943,393,768 +$614,368,368 $53.36 1,591
2017 Q2 1,263,195,777 $61,401,759,006 +$808,713,177 $48.61 1,569
2017 Q1 1,251,255,326 $55,565,381,743 +$10,527,320,695 $44.41 1,585
2016 Q4 1,106,373,205 $42,516,265,016 +$407,904,281 $38.41 1,514
2016 Q3 1,091,633,492 $46,138,705,256 +$1,153,981,971 $42.29 1,484
2016 Q2 1,067,624,130 $41,983,022,819 +$1,701,516,839 $39.31 1,467
2016 Q1 1,022,822,267 $42,778,202,179 -$173,321,678 $41.83 1,457
2015 Q4 1,027,740,304 $46,154,356,293 -$497,206,316 $44.91 1,498
2015 Q3 1,037,112,499 $41,717,834,562 +$274,539,953 $40.22 1,452
2015 Q2 1,033,961,965 $50,752,165,358 +$294,425,750 $49.08 1,478
2015 Q1 1,028,648,801 $47,650,459,140 -$625,423,849 $46.33 1,463
2014 Q4 1,043,914,792 $46,996,777,711 +$448,236,438 $45.02 1,472
2014 Q3 1,028,753,494 $42,786,861,710 +$362,567,670 $41.59 1,388
2014 Q2 1,019,994,541 $41,715,229,215 +$96,928,621 $40.9 1,377
2014 Q1 1,020,830,174 $39,305,027,565 -$1,235,422,500 $38.51 1,367